Vadim Osadchiy1, Clair R Martin1, Emeran A Mayer2. 1. G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, California. 2. G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, California. Electronic address: emayer@ucla.edu.
Abstract
BACKGROUND & AIMS: Based largely on results from preclinical studies, the concept of a brain gut microbiome axis has been established, mediating bidirectional communication between the gut, its microbiome, and the nervous system. Limited data obtained in human beings suggest that alterations in these interactions may play a role in several brain gut disorders. METHODS: We reviewed the preclinical and clinical literature related to the topic of brain gut microbiome interactions. RESULTS: Well-characterized bidirectional communication channels, involving neural, endocrine, and inflammatory mechanisms, exist between the gut and the brain. Communication through these channels may be modulated by variations in the permeability of the intestinal wall and the blood-brain barrier. Brain gut microbiome interactions are programmed during the first 3 years of life, including the prenatal period, but can be modulated by diet, medications, and stress throughout life. Based on correlational studies, alterations in these interactions have been implicated in the regulation of food intake, obesity, and in irritable bowel syndrome, even though causality remains to be established. CONCLUSIONS: Targets within the brain gut microbiome axis have the potential to become targets for novel drug development for brain gut disorders.
BACKGROUND & AIMS: Based largely on results from preclinical studies, the concept of a brain gut microbiome axis has been established, mediating bidirectional communication between the gut, its microbiome, and the nervous system. Limited data obtained in human beings suggest that alterations in these interactions may play a role in several brain gut disorders. METHODS: We reviewed the preclinical and clinical literature related to the topic of brain gut microbiome interactions. RESULTS: Well-characterized bidirectional communication channels, involving neural, endocrine, and inflammatory mechanisms, exist between the gut and the brain. Communication through these channels may be modulated by variations in the permeability of the intestinal wall and the blood-brain barrier. Brain gut microbiome interactions are programmed during the first 3 years of life, including the prenatal period, but can be modulated by diet, medications, and stress throughout life. Based on correlational studies, alterations in these interactions have been implicated in the regulation of food intake, obesity, and in irritable bowel syndrome, even though causality remains to be established. CONCLUSIONS: Targets within the brain gut microbiome axis have the potential to become targets for novel drug development for brain gut disorders.
Authors: Caroline Thum; Adrian L Cookson; Don E Otter; Warren C McNabb; Alison J Hodgkinson; Jolon Dyer; Nicole C Roy Journal: J Nutr Date: 2012-09-18 Impact factor: 4.798
Authors: Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz Journal: Science Date: 2010-03-04 Impact factor: 47.728
Authors: Javier A Bravo; Paul Forsythe; Marianne V Chew; Emily Escaravage; Hélène M Savignac; Timothy G Dinan; John Bienenstock; John F Cryan Journal: Proc Natl Acad Sci U S A Date: 2011-08-29 Impact factor: 11.205
Authors: I D Van Felius; L M A Akkermans; K Bosscha; A Verheem; W Harmsen; M R Visser; H G Gooszen Journal: Neurogastroenterol Motil Date: 2003-06 Impact factor: 3.598
Authors: Antje Damms-Machado; Suparna Mitra; Asja E Schollenberger; Klaus Michael Kramer; Tobias Meile; Alfred Königsrainer; Daniel H Huson; Stephan C Bischoff Journal: Biomed Res Int Date: 2015-02-01 Impact factor: 3.411
Authors: Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey Journal: Sci Rep Date: 2017-10-19 Impact factor: 4.379
Authors: Maria G Dominguez-Bello; Kassandra M De Jesus-Laboy; Nan Shen; Laura M Cox; Amnon Amir; Antonio Gonzalez; Nicholas A Bokulich; Se Jin Song; Marina Hoashi; Juana I Rivera-Vinas; Keimari Mendez; Rob Knight; Jose C Clemente Journal: Nat Med Date: 2016-02-01 Impact factor: 53.440
Authors: Martin Depner; Diana Hazard Taft; Pirkka V Kirjavainen; Karen M Kalanetra; Anne M Karvonen; Stefanie Peschel; Elisabeth Schmausser-Hechfellner; Caroline Roduit; Remo Frei; Roger Lauener; Amandine Divaret-Chauveau; Jean-Charles Dalphin; Josef Riedler; Marjut Roponen; Michael Kabesch; Harald Renz; Juha Pekkanen; Freda M Farquharson; Petra Louis; David A Mills; Erika von Mutius; Markus J Ege Journal: Nat Med Date: 2020-11-02 Impact factor: 53.440
Authors: James W Nelson; Sharon C Phillips; Bhanu P Ganesh; Joseph F Petrosino; David J Durgan; Robert M Bryan Journal: FASEB J Date: 2021-02 Impact factor: 5.191
Authors: Elena J L Coley; Emeran A Mayer; Vadim Osadchiy; Zixi Chen; Vishvak Subramanyam; Yurui Zhang; Elaine Y Hsiao; Kan Gao; Ravi Bhatt; Tien Dong; Priten Vora; Bruce Naliboff; Jonathan P Jacobs; Arpana Gupta Journal: Neurobiol Stress Date: 2021-05-25